These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 22440858)
21. Development of novel peptidomimetics containing a vinyl sulfone moiety as proteasome inhibitors. Ettari R; Bonaccorso C; Micale N; Heindl C; Schirmeister T; Calabrò ML; Grasso S; Zappalà M ChemMedChem; 2011 Jul; 6(7):1228-37. PubMed ID: 21506279 [TBL] [Abstract][Full Text] [Related]
22. Identification of a potent and rapidly reversible inhibitor of the 20S-proteasome. Purandare AV; Wan H; Laing N; Benbatoul K; Vaccaro W; Poss MA Bioorg Med Chem Lett; 2004 Sep; 14(18):4701-4. PubMed ID: 15324891 [TBL] [Abstract][Full Text] [Related]
23. A concise, total synthesis of the TMC-95A/B proteasome inhibitors. Albrecht BK; Williams RM Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11949-54. PubMed ID: 15163792 [TBL] [Abstract][Full Text] [Related]
24. Pharmacophore modeling, docking studies, and synthesis of novel dipeptide proteasome inhibitors containing boron atoms. Lei M; Zhao X; Wang Z; Zhu Y J Chem Inf Model; 2009 Sep; 49(9):2092-100. PubMed ID: 19691298 [TBL] [Abstract][Full Text] [Related]
26. Small-molecule inhibitors of proteasome activity. Gaczynska M; Osmulski PA Methods Mol Biol; 2005; 301():3-22. PubMed ID: 15917622 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, in vitro and in vivo biological evaluation, docking studies, and structure--activity relationship (SAR) discussion of dipeptidyl boronic acid proteasome inhibitors composed of beta-amino acids. Zhu Y; Zhu X; Wu G; Ma Y; Li Y; Zhao X; Yuan Y; Yang J; Yu S; Shao F; Li R; Ke Y; Lu A; Liu Z; Zhang L J Med Chem; 2010 Mar; 53(5):1990-9. PubMed ID: 20158184 [TBL] [Abstract][Full Text] [Related]
28. Effect of noncompetitive proteasome inhibition on bortezomib resistance. Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological characterization of argyrin F. Bülow L; Nickeleit I; Girbig AK; Brodmann T; Rentsch A; Eggert U; Sasse F; Steinmetz H; Frank R; Carlomagno T; Malek NP; Kalesse M ChemMedChem; 2010 Jun; 5(6):832-6. PubMed ID: 20358576 [No Abstract] [Full Text] [Related]
30. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Fennell DA; Chacko A; Mutti L Oncogene; 2008 Feb; 27(9):1189-97. PubMed ID: 17828309 [TBL] [Abstract][Full Text] [Related]
31. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607 [TBL] [Abstract][Full Text] [Related]
32. Proteasome inhibition by peptide-semicarbazones. Leban J; Blisse M; Krauss B; Rath S; Baumgartner R; Seifert MH Bioorg Med Chem; 2008 Apr; 16(8):4579-88. PubMed ID: 18313310 [TBL] [Abstract][Full Text] [Related]
33. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone. McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and proteasome inhibition of N-allyl vinyl ester-based peptides. Baldisserotto A; Franceschini C; Scalambra F; Trapella C; Marastoni M; Sforza F; Gavioli R; Tomatis R J Pept Sci; 2010 Nov; 16(11):659-63. PubMed ID: 20814885 [TBL] [Abstract][Full Text] [Related]
35. Proteasome inhibitors for cancer therapy. Iqbal M; Messina McLaughlin PA; Dunn D; Mallya S; Husten J; Ator MA; Chatterjee S Bioorg Med Chem; 2012 Apr; 20(7):2362-8. PubMed ID: 22377673 [TBL] [Abstract][Full Text] [Related]
36. TMC-95A, B, C, and D, novel proteasome inhibitors produced by Apiospora montagnei Sacc. TC 1093. Taxonomy, production, isolation, and biological activities. Koguchi Y; Kohno J; Nishio M; Takahashi K; Okuda T; Ohnuki T; Komatsubara S J Antibiot (Tokyo); 2000 Feb; 53(2):105-9. PubMed ID: 10805568 [TBL] [Abstract][Full Text] [Related]
37. A new series of N5 derivatives of the 1,1,5-trimethyl furo[3,4-c]pyridine-3,4-dione (cerpegin) selectively inhibits the post-acid activity of mammalian 20S proteasomes. Pham TH; Hovhannisyan A; Bouvier D; Tian L; Reboud-Ravaux M; Melikyan G; Bouvier-Durand M Bioorg Med Chem Lett; 2012 Jun; 22(11):3822-7. PubMed ID: 22560566 [TBL] [Abstract][Full Text] [Related]
38. Proteasome inhibitors; synthesis and activity of arecoline oxide tripeptide derivatives. Marastoni M; McDonald J; Baldisserotto A; Canella A; De Risi C; Pollini GP; Tomatis R Bioorg Med Chem Lett; 2004 Apr; 14(8):1965-8. PubMed ID: 15050638 [TBL] [Abstract][Full Text] [Related]
39. Hydroxyureas as noncovalent proteasome inhibitors. Gallastegui N; Beck P; Arciniega M; Huber R; Hillebrand S; Groll M Angew Chem Int Ed Engl; 2012 Jan; 51(1):247-9. PubMed ID: 22105886 [No Abstract] [Full Text] [Related]
40. Synthesis of boronic acid derivatives of tyropeptin: proteasome inhibitors. Watanabe T; Momose I; Abe M; Abe H; Sawa R; Umezawa Y; Ikeda D; Takahashi Y; Akamatsu Y Bioorg Med Chem Lett; 2009 Apr; 19(8):2343-5. PubMed ID: 19307118 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]